J. A. Carrillo

发表

Are antipsychotic drugs potentially chemopreventive agents for cancer?

J. A. Carrillo, J. Benítez, J. Benítez, 1999, European Journal of Clinical Pharmacology.

BDNF genetic variability modulates psychopathological symptoms in patients with eating disorders

G. Gervasini, R. Rodríguez-López, J. A. Carrillo, 2014, European Child & Adolescent Psychiatry.

CYP1A1 gene polymorphisms increase lung cancer risk in a high-incidence region of Spain: a case control study

G. Gervasini, J. A. Carrillo, Mercedes Jiménez, 2010, BMC Cancer.

Genetic polymorphism of CYP1A2 in Ethiopians affecting induction and expression: characterization of novel haplotypes with single-nucleotide polymorphisms in intron 1.

M. Ingelman-Sundberg, L. Bertilsson, E. Aklillu, 2003, Molecular pharmacology.

High CYP2A6 enzyme activity as measured by a caffeine test and unique distribution of CYP2A6 variant alleles in Ethiopian population.

M. Ingelman-Sundberg, L. Bertilsson, E. Aklillu, 2014, Omics : a journal of integrative biology.

Comparative Cytochrome P450 In Vitro Inhibition by Atypical Antipsychotic Drugs

G. Gervasini, J. A. Carrillo, J. Benítez, 2013, ISRN pharmacology.

Comparative Cytochrome P 450 In Vitro Inhibition by Atypical Antipsychotic Drugs

G. Gervasini, J. A. Carrillo, J. Benítez, 2015 .

GST Polymorphisms Interact With Dietary Factors to Modulate Lung Cancer Risk: Study in a High-Incidence Area

G. Gervasini, J. A. Carrillo, J. Benítez, 2010, Nutrition and cancer.

CYP1A2 activity, gender and smoking, as variables influencing the toxicity of caffeine.

J. A. Carrillo, J. Benítez, 2003, British journal of clinical pharmacology.

In vivo evaluation of CYP2A6 and xanthine oxidase enzyme activities in the Serbian population

S. Janković, G. Gervasini, E. Aklillu, 2010, European Journal of Clinical Pharmacology.

Clozapine disposition covaries with CYP1A2 activity determined by a caffeine test.

C. Alm, L. Bertilsson, A. Llerena, 1994, British journal of clinical pharmacology.

Comments to "interaction between caffeine and clozapine".

L. Bertilsson, J. A. Carrillo, M. Jerling, 1995, Journal of clinical psychopharmacology.

Debrisoquine oxidation phenotype during neuroleptic monotherapy

A. Caputi, E. Spina, J. A. Carrillo, 1990, European Journal of Clinical Pharmacology.

N-Acetyltransferase-2 (NAT2) phenotype is influenced by genotype-environment interaction in Ethiopians

L. Bertilsson, E. Aklillu, J. A. Carrillo, 2018, European Journal of Clinical Pharmacology.

Polymorphisms in ABCB1 and CYP19A1 genes affect anastrozole plasma concentrations and clinical outcomes in postmenopausal breast cancer patients

G. Gervasini, C. Jara, J. A. Carrillo, 2017, British journal of clinical pharmacology.

Differences in CYP3A5*3 Genotype Distribution and Combinations With Other Polymorphisms Between Spaniards and Other Caucasian Populations

G. Gervasini, J. A. Carrillo, J. Benítez, 2005, Therapeutic drug monitoring.

The effect of CYP2J2, CYP3A4, CYP3A5 and the MDR1 polymorphisms and gender on the urinary excretion of the metabolites of the H-receptor antihistamine ebastine: a pilot study.

G. Gervasini, J. A. Carrillo, J. Benítez, 2006, British journal of clinical pharmacology.

Xanthine oxidase activity is influenced by environmental factors in Ethiopians

M. Ingelman-Sundberg, L. Bertilsson, E. Aklillu, 2003, European Journal of Clinical Pharmacology.

Frequency of S-mephenytoin hydroxylation deficiency in 373 spanish subjects compared to other Caucasian populations

L. Bertilsson, A. Llerena, J. Reviriego, 2006, European Journal of Clinical Pharmacology.

Caffeine metabolism in a healthy Spanish population: N‐Acetylator phenotype and oxidation pathways

J. A. Carrillo, J. Benítez, 1994, Clinical pharmacology and therapeutics.

Thrombocytopenia and fatality associated with olanzapine

G. Gervasini, J. A. Carrillo, J. A. González, 2004, European Journal of Clinical Pharmacology.

Applicability of an assay for routine monitoring of highly variable concentrations of olanzapine based on HPLC with mass spectrometric detection.

G. Gervasini, J. A. Carrillo, J. Benítez, 2003, Clinical chemistry.

Clinically Significant Pharmacokinetic Interactions Between Dietary Caffeine and Medications

J. A. Carrillo, J. Benítez, Julio Benitez, 2000, Clinical pharmacokinetics.

Metabolism of ropivacaine in humans is mediated by CYP1A2 and to a minor extent by CYP3A4: An interaction study with fluvoxamine and ketoconazole as in vivo inhibitors

C. Alm, L. Bertilsson, L. Gustafsson, 1998, Clinical pharmacology and therapeutics.

Evaluation of caffeine as an in vivo probe for CYP1A2 using measurements in plasma, saliva, and urine.

C. Alm, L. Bertilsson, M. Dahl, 2000, Therapeutic drug monitoring.

Comparative in vitro and in vivo inhibition of cytochrome P450 CYP1A2, CYP2D6, and CYP3A by H2‐receptor antagonists

J. A. Carrillo, J. Benítez, C Martínez, 1999, Clinical pharmacology and therapeutics.

Melanocortin-4 receptor gene variants are not associated with binge-eating behavior in nonobese patients with eating disorders

G. Gervasini, R. Rodríguez-López, J. A. Carrillo, 2015, Psychiatric genetics.

Disposition of fluvoxamine in humans is determined by the polymorphic CYP2D6 and also by the CYP1A2 activity

C. Alm, L. Bertilsson, M. Dahl, 1996, Clinical pharmacology and therapeutics.

Potential Role of Cerebral Cytochrome P450 in Clinical Pharmacokinetics

G. Gervasini, J. A. Carrillo, J. Benítez, 2004, Clinical pharmacokinetics.

Adenosine triphosphate‐binding cassette B1 (ABCB1) (multidrug resistance 1) G2677T/A gene polymorphism is associated with high risk of lung cancer

G. Gervasini, J. A. Carrillo, J. Benítez, 2006, Cancer.

Analysis of midazolam and metabolites in plasma by high-performance liquid chromatography: probe of CYP3A.

J. A. Carrillo, J. Benítez, J. Agúndez, 1998, Therapeutic drug monitoring.

Modulation of midazolam 1-hydroxylation activity in vitro by neurotransmitters and precursors

G. Gervasini, J. A. Carrillo, J. Benítez, 2000, European Journal of Clinical Pharmacology.

N‐acetyltransferase‐2 (NAT2) Gene Polymorphisms and Enzyme Activity in Serbs: Unprecedented High Prevalence of Rapid Acetylators in a White Population

S. Janković, G. Gervasini, N. Ueda, 2011, Journal of clinical pharmacology.

Role of the Smoking-Induced Cytochrome P450 (CYP)1A2 and Polymorphic CYP2D6 in Steady-State Concentration of Olanzapine

G. Gervasini, J. A. Carrillo, J. Benítez, 2003, Journal of clinical psychopharmacology.

Pharmacogenetic testing and therapeutic drug monitoring are complementary tools for optimal individualization of drug therapy

Julio Benítez, Guillermo Gervasini, G. Gervasini, 2010, European Journal of Clinical Pharmacology.

Debrisoquine oxidation in an Italian population: a study in healthy subjects and in schizophrenic patients.

G. Campo, A. Caputi, E. Spina, 1992, Pharmacological research.

Effects of caffeine withdrawal from the diet on the metabolism of clozapine in schizophrenic patients.

J. A. Carrillo, J. Benítez, S. Ramos, 1998, Journal of clinical psychopharmacology.

Influence of TFAP2B and KCTD15 genetic variability on personality dimensions in anorexia and bulimia nervosa

G. Gervasini, R. Rodríguez-López, J. A. Carrillo, 2017, Brain and behavior.

Polymorphic oxidation of debrisoquine in lung cancer patients.

A. Llerena, C. Jara, J. A. Carrillo, 1991, European journal of cancer.

Pharmacokinetic interaction of fluvoxamine and thioridazine in schizophrenic patients.

R. Berecz, A. Llerena, J. A. Carrillo, 1999, Journal of clinical psychopharmacology.

Low daily 10‐mg and 20‐mg doses of fluvoxamine inhibit the metabolism of both caffeine (cytochrome P4501A2) and omeprazole (cytochrome P4502C19)

L. Bertilsson, M. Dahl, J. A. Carrillo, 2002, Clinical pharmacology and therapeutics.

Effect of dopamine receptor D4 (DRD4) haplotypes on general psychopathology in patients with eating disorders.

G. Gervasini, J. A. Carrillo, C. Gamero-Villarroel, 2018, Gene.

Comparisons of CYP2A6 genotype and enzyme activity between Swedes and Koreans.

L. Bertilsson, H. Roh, E. Aklillu, 2013, Drug metabolism and pharmacokinetics.

Haplotypes in the 5′‐untranslated region of the CYP1A2gene are inversely associated with lung cancer risk but do not correlate with caffeine metabolism

G. Gervasini, E. Aklillu, J. A. Carrillo, 2013, Environmental and molecular mutagenesis.

Comparison of N‐Acetyltransferase‐2 Enzyme Genotype‐Phenotype and Xanthine Oxidase Enzyme Activity Between Swedes and Koreans

L. Bertilsson, S. Karlsson, N. Ueda, 2012, Journal of clinical pharmacology.

Effect of common NAT2 variant alleles in the acetylation of the major clonazepam metabolite, 7-aminoclonazepam.

G. Gervasini, J. A. Carrillo, E. García-Martín, 2007, Drug metabolism letters.

N-Acetyltransferase-2 (NAT2) phenotype is influenced by genotype-environment interaction in Ethiopians

L. Bertilsson, E. Aklillu, J. A. Carrillo, 2018, European Journal of Clinical Pharmacology.

Impact of NEGR1 genetic variability on psychological traits of patients with eating disorders

G. Gervasini, R. Rodríguez-López, J. A. Carrillo, 2014, The Pharmacogenomics Journal.

Influence of Dopamine Polymorphisms on the Risk for Anorexia Nervosa and Associated Psychopathological Features

G. Gervasini, J. A. Carrillo, Mercedes Jiménez, 2013, Journal of clinical psychopharmacology.

Using a Computerized Drug Prescription Screening System to Trace Drug Interactions in an Outpatient Setting

Guillermo Gervasini, G. Gervasini, J. A. Carrillo, 2004, The Annals of pharmacotherapy.

Evaluation of a drug-drug interaction alert structure through the retrospective analysis of statins-macrolides co-prescriptions.

G. Gervasini, J. A. Carrillo, J. Benítez, 2005, Basic & clinical pharmacology & toxicology.

Promoting Appropriate Drug Use Through the Application of the Spanish Drug-Related Problem Classification System in the Primary Care Setting

M. Gonzalez, G. Gervasini, J. A. Carrillo, 2000, The Annals of pharmacotherapy.

Early detection of drug interactions utilizing a computerized drug prescription handling system—focus on cerivastatin–gemfibrozil

G. Gervasini, J. A. Carrillo, J. Benítez, 2004, European Journal of Clinical Pharmacology.

Polymorphisms in serotonergic genes and psychopathological traits in eating disorders.

G. Gervasini, J. A. Carrillo, Mercedes Jiménez, 2012, Journal of Clinical Psychopharmacology.

Haplotypes in the 5′‐untranslated region of the CYP1A2gene are inversely associated with lung cancer risk but do not correlate with caffeine metabolism

G. Gervasini, E. Aklillu, J. A. Carrillo, 2013, Environmental and molecular mutagenesis.